Occult primary head and neck carcinoma

Current Oncology Reports

Volumn 9, Issue 2, 2007, Pages 139-146

  Schmalbach, Cecelia E ^b   Miller, Frank R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CALCITONIN; CARBON 11; CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; CHOLINE; CYTOKERATIN; ESTROGEN RECEPTOR; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; MELAN A; PACLITAXEL; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; PROTEIN S 100; THYROGLOBULIN; ZIRCONIUM;

ANAMNESIS; ASPIRATION BIOPSY; AUDITORY SYSTEM EXAMINATION; BREAST CANCER; BRONCHOSCOPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE DURATION; DYSPHAGIA; DYSPNEA; ESOPHAGOSCOPY; FEVER; GERM CELL TUMOR; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HOARSENESS; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNGOSCOPY; LIVER CANCER; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOID TISSUE; MELANOMA; NASOPHARYNX; NECK DISSECTION; NECK TUMOR; NIGHT SWEAT; NUCLEAR MAGNETIC RESONANCE IMAGING; ODYNOPHAGIA; OTALGIA; OVARY CANCER; PALPATION; PANCREAS CANCER; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROSTATE CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; THYROID CARCINOMA; TONGUE; TONSIL; TONSILLECTOMY; WALDEYER RING; WEIGHT REDUCTION;

HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS, UNKNOWN PRIMARY;

EID: 33847414628     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-007-0012-5     Document Type: Review

References (27)

1. Braams JW, Pruim J, Kole AC, et al.: Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg 1997, 26:112-115.
2. Miller FR, Hussey D, Beeram M, et al.: Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg 2005, 131:626-629.
3. Chephea D, Koch W, Pitman K: Management of unknown primary tumor. Head Neck 2003, 25:499-504.
4. Ferris RL, Branstetter BF, Nayak JV: Diagnostic utility of positron emission tomography-computed tomography for predicting malignancy in cystic neck masses in adults. Laryngoscope 2005, 115:1979-1982.
5. Iganej S, Kagan R, Anderson P, et al.: Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck 2002, 24:236-246.
6. Mendenhall WM, Mancuso AA, Parsons JT, et al.: Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998, 20:739-744.
7. Ghosh L, Dahut W, Kakar S, et al.: Management of patients with metastatic cancer of unknown primary. Curr Probl Surg 2005, 42:12-66.
8. Wax MK, Myers LL, Gabalski EC, et al.: Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg 2002, 128:703-707.
9. Halpenny W, Hain SF, Biassoni L, et al.: FDG-PET; A possible prognostic factor in head and neck cancer. Br J Cancer 2002, 86:512-516.
10. Kostakoglu L, Goldsmith SJ: PET in the assessment of therapy response in patients with carcinoma of the head and neck and esophagus. J Nucl Med 2004, 45:56-68.
11. Jungehulsing M, Scheidhauer K, Damm M, et al.: 2 (18F) flouro-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2002, 123:294-301.
12. Zimmer LA, Branstetter BF, Nayak JV, Johnson J: Current use of 18-F-Flourodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope 2005, 115:2029-2034.
13. Nanni C, Rubello D, Castelluci P, et al.: Role of 18 F-FDG PET-CT imaging for the detection of an unknown primary tumor: preliminary results in 21 patients. Eur J Nucl Med Molecular Imaging 2005, 32:589-592.
14. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA: Diagnostic and therapeutic management of an unknown primary. Eur J Cancer 2003, 39:1990-2005.
15. Miller FR, Karnad A, Eng T, et al.: Management of the unknown primary carcinoma; the long term follow-up on a negative PET scan. Head Neck 2006, in press.
16. Colletier PJ, Garden AS, Morrison WH, et al.: Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck 1998, 20:674-681.
17. Harper CS, Mendenhall WM, Parsons JT, et al.: Cancer in neck nodes with unknown primary site: role of mucosal radiotherapy. Head Neck 1990, 12:463-469.
18. Maulard C, Housset M, Brunel P, et al.: Postoperative radiation therapy for occult cervical lymph node metastases from an occult squamous cell carcinoma. Laryngoscope 1992, 102:884-890.
19. Coster JR, Foote RL, Olsen KD, et al.: Cervical nodal metastases of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys 1992, 23:743-749.
20. Cooper JS, Pajak TG, Forastiere AA, et al.: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004, 350:1937-1944.
21. Chorost MI, McKinley B, Tschoi M: The management of the unknown primary. J Am Coll Surg 2001, 193:666-677.
22. Hunt JL, Tomaszewski JE, Montone KT: Prostatic adeno-carcinoma metastatic to the head and neck and the workup of an unknown epithelioid neoplasm. Head Neck 2004, 26:171-178.
23. Mason AC, Azari KK, Farkas LM, et al.: Metastatic adenocarcinoma of the colon presenting as a mass in the mandible. Head Neck 2005, 27:729-732.
24. Lentsch EJ, Myers JN: Melanoma of the head and neck: Current concepts in diagnosis and management. Laryngoscope 2001, 111:1209-1222.
25. Garbe C: Cutaneous melanoma: baseline and ongoing laboratory evaluation. Dermatol Ther 2005, 18:413-421.
26. Wagner JD, Schauwecker D, Davidson D, et al.: Inefficiency of F-18 flourodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early stage cutaneous melanoma. Cancer 2005, 104:570-579.
27. Briggs RD, Pouu AM, Schnadig VJ: Cystic metastases versus branchial cleft carcinoma: a diagnostic challenge. Laryngoscope 2002, 112:1010-1014.